One word, “plastics”

Way back in August of 2015 the FDA approved the first 3D-printed drug, Spritam. 3D printing is so prevalent in the medical device industry that even the FDA has a webpage on it. Recently, GE Healthcare announced it is trying to take 3D printing to the biopharmaceutical manufacturing space. Located in Uppsala, Sweden, the Innovative Design and Advanced Manufacturing Technology Center features both metal and polymer (Dustin Hoffman would call them plastics) 3D printers as well as collaborative robots. You had me at robots. The goal is to improve the manufacturing side of pharma (think lighter parts, faster production, improved design flexibility) and, by the way, Amgen is in. InsightCity recently penned another article on 3D printing. Definitely something to keep on your radar.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn